Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.6M | $48.3M | $76.6M | $127M | $192M | $296M | $322M | $280M | $334M | $380M |
| Revenue growth | — | 18.9% | 58.4% | 66.0% | 51.3% | 54.2% | 8.6% | -12.9% | 19.1% | 13.8% |
| Gross profit | — | $27.0M | $43.6M | $81.6M | — | — | — | — | — | — |
| Gross margin | — | 55.8% | 56.9% | 64.2% | — | — | — | — | — | — |
| Operating income | -$37.3M | -$20.3M | -$15.6M | -$24.5M | -$22.5M | -$29.7M | -$77.2M | -$203M | $40.8M | -$30.8M |
| Operating margin | -91.9% | -42.0% | -20.3% | -19.3% | -11.7% | -10.0% | -24.0% | -72.5% | 12.2% | -8.1% |
| Net income | -$39.5M | -$55.5M | -$46.8M | -$22.0M | -$18.7M | -$30.7M | -$76.6M | -$190M | $52.5M | -$21.4M |
| Net margin | -97.1% | -114.8% | -61.1% | -17.3% | -9.7% | -10.3% | -23.8% | -67.9% | 15.7% | -5.6% |
| EPS (diluted) | -$2.39 | -$2.38 | -$1.31 | -$0.52 | -$0.40 | -$0.59 | -$1.44 | -$3.54 | $0.93 | -$0.40 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$16.5M | -$14.3M | -$4.01M | -$2.77M | $33.4M | -$19.3M | -$25.2M | -$18.4M | $38.0M | $42.0M |
| Capital expenditures | $549K | $186K | $2.04M | — | — | — | — | $1.80M | — | — |
| Free cash flow | -$17.1M | -$14.5M | -$6.04M | — | — | — | — | -$20.2M | — | — |
| Share buybacks | — | — | — | — | $0.00 | $0.00 | $642K | $27.5M | $522K | $87.8M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $17.3M | $16.9M | $64.6M | $38.2M | $135M | $348M | $89.9M | $82.2M | $115M | $65.4M |
| Total assets | $48.8M | $83.6M | $131M | $152M | $369M | $567M | $543M | $467M | $491M | $413M |
| Total liabilities | $57.0M | $89.5M | $34.8M | $52.7M | $90.8M | $101M | $112M | $205M | $113M | $110M |
| Long-term debt | $11.4M | $18.3M | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Shareholders' equity | $19.5M | -$6.13M | $95.9M | $99.0M | $278M | $466M | $431M | $261M | $378M | $303M |
| Retained earnings | -$213M | -$268M | -$312M | -$334M | -$353M | -$383M | -$460M | -$678M | -$626M | -$735M |
| Shares (wtd avg diluted) | 16.5M | 23.3M | 35.6M | 42.2M | 46.5M | 52.2M | 53.3M | 53.8M | 56.6M | 53.3M |
Every figure is extracted from CareDx, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.